C0210657||pemetrexed
C0079925||miR-21 antisense oligonucleotide
C0023779||lipid
C0032521||polymer
C0017636||glioblastoma
C0007634||cells
C0009429||Combination therapy
C0003392||anticancer drugs
C0028606||nucleic acid
C0027651||cancer
C0162638||apoptosis
C2603343||study
C0023779||lipid
C0032521||polymer
C1713964||lipid - polymer hybrid nanoparticles
C0210657||pemetrexed
C0079925||miR-21 antisense oligonucleotide
C0079925||anti-miR-21
C0017636||glioblastoma
C0006118||brain tumor
C1713964||lipid - polymer hybrid nanoparticles
C0681814||release experiments
C1713964||lipid - polymer hybrid nanoparticles
C0678118||transmission electron microscopy
C1713964||lipid - polymer hybrid nanoparticles
C0456389||size
C0210657||pemetrexed
C0210657||pemetrexed
C1713964||lipid - polymer hybrid nanoparticles
C0007613||cellular uptake
C0242842||confocal microscopy analysis
C0079925||anti-miR-21
C4055506||accumulation
C1713964||lipid - polymer hybrid nanoparticles
C0007610||nucleus
C0007634||U87MG cells
C0596402||cytotoxicity
C0079925||anti-miR-21
C1713964||lipid - polymer hybrid nanoparticles
C0085104||drug delivery systems
C0079925||anti-miR-21
C0087111||treatment
C0017636||glioblastoma